CARDBiomedBench: A Benchmark for Evaluating Large Language Model Performance in Biomedical Research
Owen Bianchi(National Institutes of Health), Faraz Faghri(National Institute of Neurological Disorders and Stroke), Kristin Levine(National Institutes of Health), Paige Jarreau(National Institutes of Health), Chelsea X. Alvarado(National Institutes of Health), Hampton L. Leonard(National Institutes of Health), Mike A. Nalls(University of Namur), Sara Bandrés‐Ciga(National Institutes of Health), Mathew J. Koretsky(National Institutes of Health), Daniel Khashabi(Johns Hopkins University), Mary B. Makarious(National Institutes of Health), Cory A. Weller(National Institutes of Health), Maya Willey(National Institutes of Health), Marzieh Khani(National Institute of Neurological Disorders and Stroke), Dan Vitale(National Institutes of Health), Anant Dadu(National Institutes of Health), Hirotaka Iwaki(National Institute of Neurological Disorders and Stroke), Benjamin Danek(National Institutes of Health), Sung-Won Kim(National Institutes of Health), Andrew Singleton(Laboratory of Molecular Genetics), Nicole Kuznetsov(National Institutes of Health), Syed Islamuddin Shah(National Institutes of Health), Shekoufeh Mokhtari(Data Tecnica International (United States)), Elise Marsan(National Institutes of Health)
Cited by 3
Related Papers
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database
|PLoS Genetics|2012|543
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
|The Lancet Neurology|2015|508